Silence Therapeutics Strengthens Executive Leadership Team with Key Appointments

Curtis Rambaran, MD, promoted to Chief Medical Officer Marie Wikström Lindholm, PhD, promoted to Chief Scientific Officer December 01, 2023 07:00 AM Eastern Standard Time LONDON–(BUSINESS WIRE)–Silence Therapeutics plc, Nasdaq: SLN (“Silence” or the “Company”), an experienced and innovative biotechnology company committed to transforming people’s lives by silencing diseases through precision engineered medicines, today announced Curtis Rambaran, MD, previously Silence’s Vice President, Head of Clinical … Continue reading Silence Therapeutics Strengthens Executive Leadership Team with Key Appointments

Impact Newswire06/12/202306/12/2023

Global, Untied Kingdom

Mytos Announces $19M Series A Funding to Automate Human Cell Manufacturing and Further Accelerate Growth

November 30, 2023 08:00 AM Eastern Standard Time LONDON–(BUSINESS WIRE)–Mytos, an innovative leader in automated cell manufacturing, announced today it has closed $19M in Series A financing led by Buckley Ventures, with participation from IQ Capital and Wing VC. “Mytos is revolutionizing cell manufacturing, providing a simple solution that pharma and biotech companies can easily integrate into their research workflow”Post this The funding will accelerate … Continue reading Mytos Announces $19M Series A Funding to Automate Human Cell Manufacturing and Further Accelerate Growth

Impact Newswire05/12/202305/12/2023

Global, United States

BioSkryb Genomics Appoints Genomics Industry Veteran Ram Laxman as Chief Commercial Officer

Ram Laxman brings executive leadership experience from 10x Genomics, Illumina, and Pacific Biosciences to expand BioSkryb’s international footprint November 29, 2023 09:00 AM Eastern Standard Time DURHAM, N.C.–(BUSINESS WIRE)–BioSkryb Genomics, a company transforming single-cell analysis by enabling the most complete multiomic view of the cellular ecosystem, from discovery to diagnostics, has appointed Ram Laxman, Ph.D., as Chief Commercial Officer. Dr. Laxman will lead sales and … Continue reading BioSkryb Genomics Appoints Genomics Industry Veteran Ram Laxman as Chief Commercial Officer

Impact Newswire04/12/202304/12/2023

Global, United States

Aro Biotherapeutics Secures $41.5M Series B Financing

– Funds will support progression of Aro’s pipeline of Centyrin-siRNA programs, including ABX1100, a novel potential treatment for Pompe Disease. – Christopher Picariello, President, Johnson & Johnson Innovation – JJDC, Inc. named to Board of Directors. November 28, 2023 09:00 AM Eastern Standard Time PHILADELPHIA–(BUSINESS WIRE)–Aro Biotherapeutics, a clinical stage biotechnology company pioneering the development of tissue-targeted genetic medicines, today announced it has secured $41.5M in a … Continue reading Aro Biotherapeutics Secures $41.5M Series B Financing

Impact Newswire02/12/202302/12/2023

Global, United States

Zura Bio Appoints Arnout Ploos van Amstel to its Board of Directors

Arnout Ploos van Amstel (Photo: Business Wire) November 14, 2023 06:00 AM Eastern Standard Time HENDERSON, Nev.–(BUSINESS WIRE)–Zura Bio Limited (Nasdaq: ZURA) (“Zura Bio”), a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders, announced the Board of Directors appointed Arnout Ploos van Amstel as Non-Executive Independent Director by way of co-optation. Mr. Ploos van Amstel replaces Dr. Garry Neil who … Continue reading Zura Bio Appoints Arnout Ploos van Amstel to its Board of Directors

Impact Newswire17/11/202323/01/2025

Global, United States

Resilience Appoints Bill Marth as President of Services

November 07, 2023 08:00 AM Eastern Standard Time SAN DIEGO–(BUSINESS WIRE)–National Resilience, Inc. (Resilience), a technology-focused biomanufacturing company dedicated to broadening access to complex medicines, today announced that William S. Marth, RPh., MBA has been appointed to the newly created role of President of Services. “I am thrilled to join the esteemed executive team at Resilience, and I look forward to partnering with the team to … Continue reading Resilience Appoints Bill Marth as President of Services

Impact Newswire14/11/202314/11/2023

Global, United States

I2Pure Hires Healthcare Industry Leader as Chief Executive Officer

Jeffrey Jochims Assumes Role of I2Pure CEO November 07, 2023 08:30 AM Eastern Standard Time ASHBURN, Va.–(BUSINESS WIRE)–Today, I2Pure announced the hiring of its new Chief Executive Officer, Jeffrey Jochims, effective November 1, 2023. Jeff succeeds I2Pure Founder Douglas Spitz, who is transitioning to the role of Executive Chair. Jochims also joins the I2Pure Board of Directors. “I2Pure has made tremendous progress since our formation … Continue reading I2Pure Hires Healthcare Industry Leader as Chief Executive Officer

Impact Newswire13/11/202313/11/2023

Global, United States

Terremoto Biosciences Closes $175 Million Series B Financing

– Proceeds to advance the company’s platform and support the progress of multiple in-house discovery and development programs targeting diseases of high unmet medical need – Participating investors include EcoR1 Capital, Novo Holdings, Cormorant Capital, OrbiMed and Third Rock Ventures November 02, 2023 08:00 AM Eastern Daylight Time SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Terremoto Biosciences, a biotechnology company developing highly targeted, small molecule medicines, today announced the closing … Continue reading Terremoto Biosciences Closes $175 Million Series B Financing

Impact Newswire09/11/202309/11/2023

Global, United States

Rapport Therapeutics Appoints Chief Financial Officer

October 30, 2023 09:00 AM Eastern Daylight Time BOSTON & SAN DIEGO–(BUSINESS WIRE)–Rapport Therapeutics, Inc., a clinical-stage biotechnology company leveraging the science of receptor-associated proteins (RAPs) to advance precision neuromedicines, today announced the appointment of industry veteran Troy Ignelzi as Chief Financial Officer, effective November 1, 2023. “Rapport’s innovative scientific approach to precision neuromedicine, which creates tremendous opportunity to dramatically improve patient outcomes, is incredibly … Continue reading Rapport Therapeutics Appoints Chief Financial Officer

Impact Newswire02/11/202302/11/2023